Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Neuroone Medical Technologies - SIC # 3845 - ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
NMTC
Nasdaq
3845
https://nmtc1.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Neuroone Medical Technologies
NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology
- Apr 10th, 2024 1:00 pm
NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes
- Apr 9th, 2024 1:05 pm
NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.
- Apr 4th, 2024 1:00 pm
NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System
- Mar 26th, 2024 1:00 pm
NeuroOne® to Participate in the 36th Annual Roth Conference
- Mar 8th, 2024 5:00 pm
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Feb 23rd, 2024 10:10 pm
NeuroOne Medical Technologies First Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line
- Feb 15th, 2024 12:04 pm
NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
- Feb 13th, 2024 9:00 pm
NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13
- Feb 8th, 2024 8:30 pm
NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update
- Dec 14th, 2023 9:15 pm
NeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™ Ablation System
- Dec 11th, 2023 1:00 pm
NeuroOne® to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14
- Dec 7th, 2023 9:30 pm
NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe
- Nov 16th, 2023 1:00 pm
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Nov 14th, 2023 10:15 pm
NeuroOne® Provides Progress Update on FDA 510(k) Submission for OneRF™ Ablation System
- Nov 7th, 2023 1:00 pm
NeuroOne® to Present at the ThinkEquity Conference on October 19, 2023
- Oct 13th, 2023 1:30 pm
Insider Buying: CFO Ronald Mcclurg Acquires 50,900 Shares of NeuroOne Medical Technologies Corp ...
- Sep 15th, 2023 5:01 am
NeuroOne® to Present at the H.C. Wainwright 25th Annual Global Investment Conference
- Sep 6th, 2023 8:00 pm
NeuroOne® Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update
- Aug 14th, 2023 8:00 pm
NeuroOne® to Report Third Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on August 14
- Aug 8th, 2023 8:00 pm
Scroll